Recent research has demonstrated a connection between Complement Factor H, a complement regulatory protein, and a variety of disease states including cardiovascular disease, hemolytic uremia syndrome, age related macular degeneration (AMD) and some cancers. Quidel offers several immunoreagents for Factor H research including new inhibitory monoclonal
antibodies. Quidel offers a wide range of products for complement research including specific assays for complement activation products, monoclonal and polyclonal antibodies, purified proteins and cobra venom factor.
|
1-866-394-2881